Crit Care 2007, 11:R31. 22. Levey AS, Coresh
Omes in acute kidney injury. Crit Care 2007, 11:R31. 22. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F: Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006, 145:247?54. 23. Kushner FG, Hand M, Smith SC, King SB, Anderson JL, Antman EM, Bailey SR, Bates ER, Blankenship JC, Casey DE: 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/12027669 Task Force on Practice Guidelines. J Am Coll Cardiol 2009, 54:2205?241. 24. Lazzeri C, Valente S, Chiostri M, Picariello C, Attana P, Gensini GF: Microalbuminuria in non-diabetic STEMI: an independent predictor for acute kidney injury. Scand Cardiovasc J 2012, 46:324?29. 25. Mielniczuk LM, Pfeffer MA, Lewis EF, Blazing MA, de Lemos JA, Mohanavelu S, Rouleau J, Fox K, Pedersen TR, Califf RM: Acute decline in renal function, inflammation, and cardiovascular risk after an acute coronary syndrome. Clin J Am Soc Nephrol 2009, 4:1811?817. 26. Bisoendial RJ, Kastelein JJ, Levels JH, Zwaginga JJ, van den Bogaard B, Reitsma PH, Meijers JC, Hartman D, Levi M, Stroes ES: Activation of inflammation (E)-1,2-Di(pyridin-4-yl)ethene and coagulation after infusion of C-reactive protein in humans. Circ Res 2005, 96:714?16. 27. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW: C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999, 19:972?78. 28. Tang A, Alexiou C, Hsu J, Sheppard SV, Haw MP, Ohri SK: Leukodepletion reduces renal injury in coronary revascularization: a prospective randomized study. Ann Thorac Surg 2002, 74:372?77. 29. Levi M, Ten Cate H: Disseminated intravascular 2-Bromo-1,3-difluoro-4-nitrobenzene coagulation. N Engl J Med 1999, 341:586?92. 30. Constans J, 9-diazaspiro[5.5]undecane Ethyl 5-cyclopropyl-1H-pyrazole-3-carboxylate Hydroxy-PEG2-(CH2)2-Boc 7-Chloro-1 Conri C: Circulating markers of endothelial function in cardiovascular disease. Clin Chim Acta 2006, 368:33?7.Liu et al. Critical Care 2014, 18:R100 http://ccforum.com/content/18/3/RPage 8 of31. Blann AD, Amiral J, McCollum CN: Prognostic value of increased soluble thrombomodulin and increased soluble E-selectin in ischaemic heart disease. Eur J Haematol 1997, 59:115?20. 32. Olivot JM, Labreuche J, Aiach M, Amarenco P: Soluble thrombomodulin and brain infarction: case ontrol and prospective study. Stroke 2004, 35:1946?951. 33. Jaski BE, Cohen JD, Trausch J, Marsh DG, Bail GR, Overlie PA, Skowronski EW, Smith SC Jr: Outcome of urgent percutaneous transluminal coronary angioplasty in acute myocardial infarction: comparison of single-vessel versus multivessel coronary artery disease. PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/22993420 Am Heart J 1992, 124:1427?433. 34. Matijs VM, Kumpers P, Ligtenberg JJM, Meertens JHJM, Molema G, Zijlstra JG: Bench-to-bedside review: angiopoietin signalling in critical illness ?a future target? Crit Care 2009, 13:207. 35. Davis B, Dei Cas A, Long DA, White KE, Hayward A, Ku C-H, Woolf AS, Bilous R, Viberti G, Gnudi L: Podocyte-specific expression of angiopoietin-2 causes proteinuria and apoptosis of glomerular endothelia. J Am Soc Nephrol 2007, 18:2320?329. 36. Eleuteri E, Di Stefano A, Genta FT, Vicari C, Gnemmi I, Colom.